| 000 | 01622 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515010645.0 | ||
| 264 | 0 | _c20060420 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0195-6701 | ||
| 024 | 7 |
_a10.1016/j.jhin.2005.04.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrown, D F J | |
| 245 | 0 | 0 |
_aNational glycopeptide-resistant enterococcal bacteraemia surveillance Working Group report to the Department of Health - August 2004. _h[electronic resource] |
| 260 |
_bThe Journal of hospital infection _cMar 2006 |
||
| 300 |
_aS1-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aEnterococcus _xdrug effects |
| 650 | 0 | 4 |
_aGlycopeptides _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLaboratories, Hospital |
| 650 | 0 | 4 |
_aPopulation Surveillance _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aBrown, N M | |
| 700 | 1 | _aCookson, B D | |
| 700 | 1 | _aDuckworth, G | |
| 700 | 1 | _aFarrington, M | |
| 700 | 1 | _aFrench, G L | |
| 700 | 1 | _aKing, L | |
| 700 | 1 | _aLewis, D | |
| 700 | 1 | _aLivermore, D M | |
| 700 | 1 | _aMacrae, B | |
| 700 | 1 | _aScott, G M | |
| 700 | 1 | _aWilliams, D | |
| 700 | 1 | _aWoodford, N | |
| 773 | 0 |
_tThe Journal of hospital infection _gvol. 62 Suppl 1 _gp. S1-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhin.2005.04.011 _zAvailable from publisher's website |
| 999 |
_c15959202 _d15959202 |
||